BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 15910290)

  • 21. Reducing thrombotic complications in the perioperative setting: an update on heparin-induced thrombocytopenia.
    Levy JH; Tanaka KA; Hursting MJ
    Anesth Analg; 2007 Sep; 105(3):570-82. PubMed ID: 17717208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.
    Carrier M; Knoll GA; Kovacs MJ; Moore JC; Fergusson D; Rodger MA
    Thromb Res; 2007; 120(2):215-20. PubMed ID: 17098277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole blood impedance aggregometry detects heparin-induced thrombocytopenia antibodies.
    Morel-Kopp MC; Aboud M; Tan CW; Kulathilake C; Ward C
    Thromb Res; 2010 May; 125(5):e234-9. PubMed ID: 20053425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Platelet factor 4, target of anti-heparin antibodies: application to biological diagnosis of heparin-induced thrombopenia].
    Amiral J
    Ann Med Interne (Paris); 1997; 148(2):142-9. PubMed ID: 9238439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparin-induced thrombocytopenia: natural history, diagnosis, and management.
    Deitcher SR; Carman TL
    Vasc Med; 2001; 6(2):113-9. PubMed ID: 11530963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparin-induced thrombocytopenia in left ventricular assist device bridge-to-transplant patients.
    Schroder JN; Daneshmand MA; Villamizar NR; Petersen RP; Blue LJ; Welsby IJ; Lodge AJ; Ortel TL; Rogers JG; Milano CA
    Ann Thorac Surg; 2007 Sep; 84(3):841-5; discussion 845-6. PubMed ID: 17720387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The approach to heparin-induced thrombocytopenia.
    Linkins LA; Warkentin TE
    Semin Respir Crit Care Med; 2008 Feb; 29(1):66-74. PubMed ID: 18302088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparin-induced thrombocytopenia: an overview.
    Kelton JG
    Blood Rev; 2002 Mar; 16(1):77-80. PubMed ID: 11914002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of heparin-induced thrombocytopenia on postoperative outcomes after cardiac surgery.
    Kerendi F; Thourani VH; Puskas JD; Kilgo PD; Osgood M; Guyton RA; Lattouf OM
    Ann Thorac Surg; 2007 Nov; 84(5):1548-53; discussion 1554-5. PubMed ID: 17954061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparin-induced thrombocytopenia: diagnosis and management.
    Hassell K
    Thromb Res; 2008; 123 Suppl 1():S16-21. PubMed ID: 18829068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia.
    Zwicker JI; Uhl L; Huang WY; Shaz BH; Bauer KA
    J Thromb Haemost; 2004 Dec; 2(12):2133-7. PubMed ID: 15613017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Newer insights on the mechanism of heparin-induced thrombocytopenia.
    Walenga JM; Jeske WP; Prechel MM; Bakhos M
    Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():57-67. PubMed ID: 15085467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What is the potential for overdiagnosis of heparin-induced thrombocytopenia?
    Lo GK; Sigouin CS; Warkentin TE
    Am J Hematol; 2007 Dec; 82(12):1037-43. PubMed ID: 17722079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin-induced thrombocytopenia: some working hypotheses on pathogenesis, diagnostic strategies and treatment.
    Alberio L
    Curr Opin Hematol; 2008 Sep; 15(5):456-64. PubMed ID: 18695368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donor heparinization is not a contraindication to liver transplantation even in recipients with acute heparin-induced thrombocytopenia type II: a case report and review of the literature.
    Bachmann R; Nadalin S; Li J; Lange J; Ladurner R; Königsrainer A; Heininger A
    Transpl Int; 2011 Oct; 24(10):e89-92. PubMed ID: 21884552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased prevalence of heparin-induced thrombocytopenia with low-molecular-weight heparin and related drugs.
    Walenga JM; Jeske WP; Prechel MM; Bacher P; Bakhos M
    Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():69-80. PubMed ID: 15085468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A critical evaluation of assays for detecting antibodies to the heparin-PF4 complex.
    Francis JL
    Semin Thromb Hemost; 2004 Jun; 30(3):359-68. PubMed ID: 15282659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of plasma exchange in patients with heparin-induced thrombocytopenia: a report of two cases and a review of the literature.
    Jaben EA; Torloni AS; Pruthi RK; Winters JL
    J Clin Apher; 2011; 26(4):219-24. PubMed ID: 21506142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heparin-induced thrombocytopenia in patients with ventricular assist devices: are new prevention strategies required?
    Warkentin TE; Greinacher A; Koster A
    Ann Thorac Surg; 2009 May; 87(5):1633-40. PubMed ID: 19379937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparin-induced thrombocytopenia: clinical manifestations and management strategies.
    Menajovsky LB
    Am J Med; 2005 Aug; 118 Suppl 8A():21S-30S. PubMed ID: 16125511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.